{"id":"siklos","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Infections","drugRate":"40%","severity":"common","organSystem":""},{"effect":"Blood and lymphatic system disorders","drugRate":"21%","severity":"common","organSystem":""},{"effect":"Other Infections","drugRate":"23%","severity":"common","organSystem":""},{"effect":"Neutropenia","drugRate":"13%","severity":"common","organSystem":""},{"effect":"Bacterial infections","drugRate":"16%","severity":"common","organSystem":""},{"effect":"Thrombocytopenia","drugRate":"7%","severity":"common","organSystem":""},{"effect":"Viral infections","drugRate":"10%","severity":"common","organSystem":""},{"effect":"Anemia","drugRate":"4.2%","severity":"common","organSystem":""},{"effect":"Parvovirus B19","drugRate":"4%","severity":"common","organSystem":""},{"effect":"Headache","drugRate":"","severity":"common","organSystem":""},{"effect":"Dry skin","drugRate":"","severity":"common","organSystem":""},{"effect":"Skin depigmentation/melanonychia","drugRate":"","severity":"common","organSystem":""},{"effect":"Skin rash","drugRate":"","severity":"common","organSystem":""},{"effect":"Alopecia","drugRate":"","severity":"common","organSystem":""},{"effect":"Gastrointestinal disorders","drugRate":"","severity":"common","organSystem":""},{"effect":"Vitamin D deficiency","drugRate":"","severity":"common","organSystem":""},{"effect":"Macrocytosis","drugRate":"","severity":"common","organSystem":""},{"effect":"Vomiting","drugRate":"","severity":"common","organSystem":""},{"effect":"Elevation of hepatic enzymes","drugRate":"","severity":"common","organSystem":""},{"effect":"Oral mucositis","drugRate":"","severity":"common","organSystem":""}],"contraindications":["Anemia","Breastfeeding (mother)","Kidney disease","Leukopenia","Postirradiation Erythema","Pregnancy, function","Severe Bone Marrow Depression","Thrombocytopenic disorder","Vasculitis of the skin"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Infections","drugRate":"18%","severity":"serious"},{"effect":"Nervous system disorders","drugRate":"4%","severity":"serious"},{"effect":"Blood and lymphatic system disorders","drugRate":"9%","severity":"serious"},{"effect":"Serious neutropenia","drugRate":"3.2%","severity":"serious"},{"effect":"Gastrointestinal disorders","drugRate":"3.2%","severity":"serious"},{"effect":"Thrombocytopenia","drugRate":"3%","severity":"serious"},{"effect":"Anemia","drugRate":"3%","severity":"serious"},{"effect":"Fever","drugRate":"2.5%","severity":"serious"},{"effect":"Headache","drugRate":"2.7%","severity":"serious"},{"effect":"Respiratory, thoracic and mediastinal disorders","drugRate":"5.8%","severity":"serious"}]},"trials":[],"_chembl":{"chemblId":"CHEMBL467","moleculeType":"Small molecule","molecularWeight":"76.05"},"aliases":["hydroxyurea","hydrocarbamide"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"76957c0d-0f98-4376-bb06-eee651adc09d","title":"SIKLOS (HYDROXYUREA) TABLET, FILM COATED [MEDUNIK]"},"ecosystem":[],"mechanism":{"target":"Carbonic anhydrase 2, Carbonic anhydrase 5A, mitochondrial, Carbonic anhydrase 9"},"_scrapedAt":"2026-03-28T00:07:55.511Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Chronic myeloid leukemia","diseaseId":"chronic-myeloid-leukemia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Hb SS disease","diseaseId":"hb-ss-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Hemoglobin SS disease with crisis","diseaseId":"hemoglobin-ss-disease-with-crisis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Malignant melanoma","diseaseId":"malignant-melanoma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Malignant tumor of head and/or neck","diseaseId":"malignant-tumor-of-head-and/or-neck","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Malignant tumor of ovary","diseaseId":"malignant-tumor-of-ovary","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Sickling disorder due to hemoglobin S","diseaseId":"sickling-disorder-due-to-hemoglobin-s","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03806452","phase":"PHASE2","title":"SIKAMIC (SIklos on Kidney Function and AlbuMInuria Clinical Trial)","status":"COMPLETED","sponsor":"Theravia","startDate":"2019-05-28","conditions":"Sickle Cell Disease","enrollment":86},{"nctId":"NCT04750707","phase":"PHASE3","title":"Hydroxyurea Therapy for Neurological and Cognitive Protection in Pediatric Sickle Cell Anemia in Uganda ( BRAINSAFE-II )","status":"COMPLETED","sponsor":"Global Health Uganda LTD","startDate":"2021-03-09","conditions":"Sickle Cell Anemia in Children","enrollment":270},{"nctId":"NCT06464458","phase":"NA","title":"Optimizing the Management of Sickle Cell Patients on Hydroxyurea: The Value of Therapeutic Pharmacological Monitoring","status":"RECRUITING","sponsor":"University Hospital, Strasbourg, France","startDate":"2023-02-08","conditions":"Sickle Cell Disease","enrollment":30},{"nctId":"NCT04707235","phase":"","title":"ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Theravia","startDate":"2020-08-21","conditions":"Sickle Cell Disease","enrollment":2093},{"nctId":"NCT02522104","phase":"PHASE4","title":"Evaluation of the Impact of Renal Function on the Pharmacokinetics of SIKLOS ® (DARH)","status":"COMPLETED","sponsor":"Theravia","startDate":"2015-09-03","conditions":"Sickle Cell Disease, Renal Function Disorder","enrollment":40},{"nctId":"NCT05025072","phase":"PHASE1","title":"A Bioequivalence Study to Compare the Pharmacokinetics of Two Formulations of Siklos® in Healthy Volunteers","status":"COMPLETED","sponsor":"Theravia","startDate":"2021-08-22","conditions":"Healthy Volunteers","enrollment":28},{"nctId":"NCT02042222","phase":"EARLY_PHASE1","title":"Novel Dose Escalation to Predict Treatment With Hydroxyurea","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2013-10","conditions":"Sickle Cell Disease","enrollment":70},{"nctId":"NCT02516579","phase":"","title":"European Sickle Cell Disease Cohort - Hydroxyurea","status":"COMPLETED","sponsor":"Theravia","startDate":"2009-01","conditions":"Sickle Cell Disease","enrollment":1906},{"nctId":"NCT03128515","phase":"PHASE3","title":"Optimizing Hydroxyurea Therapy in Children With SCA In Malaria Endemic Areas","status":"COMPLETED","sponsor":"Indiana University","startDate":"2017-07-26","conditions":"Sickle Cell Anemia, Sickle Cell Disease, Malaria","enrollment":187},{"nctId":"NCT01976416","phase":"PHASE3","title":"Novel Use Of Hydroxyurea in an African Region With Malaria","status":"COMPLETED","sponsor":"Indiana University","startDate":"2014-09","conditions":"Sickle Cell Anemia, Sickle Cell Disease, Malaria","enrollment":208},{"nctId":"NCT02957760","phase":"PHASE2","title":"Prevention of Retinal Non-perfusion in Central Retinal Vein Occlusion by Hydroxycarbamide Treatment.","status":"UNKNOWN","sponsor":"Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts","startDate":"2015-12","conditions":"Central Retinal Vein Occlusion, Non-Ischemic","enrollment":30}],"_emaApprovals":[],"_faersSignals":[{"count":76,"reaction":"SICKLE CELL ANAEMIA WITH CRISIS"},{"count":18,"reaction":"OFF LABEL USE"},{"count":17,"reaction":"PAIN"},{"count":16,"reaction":"FATIGUE"},{"count":12,"reaction":"HEPATIC CYTOLYSIS"},{"count":11,"reaction":"ACUTE CHEST SYNDROME"},{"count":9,"reaction":"DYSPNOEA"},{"count":9,"reaction":"EOSINOPHILIA"},{"count":9,"reaction":"PLASMA CELL MYELOMA"},{"count":8,"reaction":"ABDOMINAL PAIN"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[{"date":"20181212","type":"SUPPL","sponsor":"THERAVIA","applicationNumber":"NDA208843"},{"date":"20231128","type":"SUPPL","sponsor":"THERAVIA","applicationNumber":"NDA208843"},{"date":"20190522","type":"SUPPL","sponsor":"THERAVIA","applicationNumber":"NDA208843"},{"date":"20171221","type":"ORIG","sponsor":"THERAVIA","applicationNumber":"NDA208843"},{"date":"20211207","type":"SUPPL","sponsor":"THERAVIA","applicationNumber":"NDA208843"}],"developmentCodes":[],"ownershipHistory":[],"publicationCount":12,"therapeuticAreas":["Oncology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Siklos","genericName":"Siklos","companyName":"Theravia","companyId":"theravia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}